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Abstract: Sub-micron o/w emulsions coated with chitosan have been used for drug delivery,
quorum sensing inhibition, and vaccine development. To study interactions with biological systems,
nanocapsules have been fluorescently labelled in previous works, but it is often difficult to distinguish
the released label from intact nanocapsules. In this study, we present advanced-labelling strategies
based on Förster Resonance Energy Transfer (FRET) measurements for chitosan-coated nanocapsules
and investigate their dissolution and degradation. We used FRET measurements of nanocapsules
loaded with equimolar concentrations of two fluorescent dyes in their oily core and correlated
them with dynamic light scattering (DLS) count rate measurement and absorbance measurements
during their disintegration by dissolution. Using count rate measurements, we also investigated
the enzymatic degradation of nanocapsules using pancreatin and how protein corona formation
influences their degradation. Of note, nanocapsules dissolved in ethanol, while FRET decreased
simultaneously with count rate, and absorbance was caused by nanocapsule turbidity, indicating
increased distance between dye molecules after their release. Nanocapsules were degradable by
pancreatin in a dose-dependent manner, and showed a delayed enzymatic degradation after protein
corona formation. We present here novel labelling strategies for nanocapsules that allow us to
judge their status and an in vitro method to study nanocapsule degradation and the influence of
surface characteristics.
Keywords: chitosan; nanocapsules; degradation; FRET; protein corona; bioimaging
1. Introduction
Nanomedicine has been gaining traction over the past few decades, particularly in drug delivery,
diagnosis, and medical imaging research. Many applications are currently being investigated, in clinical
trials, or have already been commercialised. Pharmaceutical formulations clinically approved include
liposomes [1,2], albumin nanoparticles [3], and polymeric micelles [4]. The advocated advantages of
these systems are enhanced drug delivery options and feasibility of other therapeutics that are normally
challenging to deliver owing to free molecules issues [4], prolonged circulation time [3,5] or specific
targeting [6,7].
Despite the effectiveness of these systems, their mode of action begs unanswered questions
and leaves much to be understood. Indeed, the mechanisms whereby macromolecular drugs
and nanoparticles offer advantages over conventional dosage forms were previously thought to
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be established. Such was the case of the enhanced permeability and retention (EPR) effect in the
passive targeting of nanoparticles for cancer tumours [8–10], mostly by systemic delivery; it has been
recently questioned as being more nuanced than previously thought, with several properties of
the nanoparticles and patient characteristics influencing its effectiveness [6,7]. Multiple biological
processes are thought to be at play when accounting for differences found in the EPR effect of
different type of nanoparticles (e.g., interactions of proteins present in body fluids and formation of
nanoparticles protein corona, and differences in extravasation and subsequent interaction with
the tumour microenvironment). To make educated statements about the relevancy of the EPR of
nanoparticles in a certain pathology, the properties of nanoparticles that influence the previously
mentioned biological processes should be studied in detail, i.e., size, shape, surface makeup, charge,
density, etc. Some of these biological processes can be studied in vitro, like the formation of protein
corona [11]. Investigating other processes, like extravasation and tumour accumulation, can be
more challenging and must be studied in or ex vivo models using magnetic resonance imaging or
fluorescence microscopy. Another challenging aspect in studying the systemic delivery of nanoparticles
are their circulation times and degradation and metabolic pathways. Nanoparticles injected into the
bloodstream are mostly cleared by opsonization and the mononuclear phagocyte system in the liver,
spleen, lungs, and bone marrow [12]. On the other hand, nanoparticles intended for transmucosal
oral delivery (inherent greater patient compliance than any other administration route) are mainly
used to enhance the bioavailability of drugs, particularly highly insoluble, non-Lipinski molecules, and
delicate biological macromolecules (known also as “biologics”). They face a different set of challenges
because of the acidic conditions encountered in the gastric tract and abundance of degradative enzymes
as part of the digestive system [13]. The study of the release of drugs or other therapeutic molecules like
siRNA from nanocarriers, and their bioimaging upon oral or systemic administration still face unmet
challenges. Often, these gaps have to be addressed on a case-by-case basis. Similar to the study of the
EPR effect of nanocarriers cellular uptake, drug release kinetics and the associated mechanistic aspects
in vitro or in vivo can all be highly variable and dependent on the physicochemical characteristics of
both drug and the nanocarrier, as well as the physiological context [14–19].
Förster resonance energy transfer (FRET) is the transfer of energy from an excited donor
chromophore to an acceptor chromophore and occurs if the emission spectrum of the former is
overlapping with the absorption spectrum of the latter, given their distance is below 10 nm and the
molecules are in a certain steric orientation. It has been widely used to study conformation changes
in proteins and has been called the ‘spectroscopic ruler’ [20]. More recently, FRET measurements
have been applied to the in vitro and in vivo study of nanoparticle systems, to expand upon previously
used simple fluorescent labelling [21–25]. FRET measurements with nanoparticles can determine
whether they are still in their intact state or have been degraded, since FRET is rapidly lost when the
proximity of donor and acceptor increases. This is advantageous when compared to simple fluorescent
labelling, where it is often difficult to tell if the label is still associated with the nanoparticles or
was released.
Nanoemulsions (NEs) are liquid sub-micron colloidal oil droplets dispersed in water (o/w)
with a lipophilic oily core, usually stabilized by a surfactant covered interface with the aqueous
phase. In drug delivery applications, NEs are mostly used to deliver lipophilic drugs with a low
bioavailability loaded into their hydrophobic core, like previously mentioned polymeric micelles.
Hydrophilic therapeutic large macromolecules like proteins or nucleic acids can also be loaded onto
the shell of the system by adsorbing them. The o/w interface can be coated with a polymer too,
usually by electrostatic interactions between the surfactant and an oppositely charged polyelectrolyte,
giving rise to a nanocapsule (NC) system with different physicochemical properties. By coating
nanoemulsions with a negative zeta potential with the cationic polymer chitosan (CS), NCs with
a positive surface charge are obtained. Such chitosan-coated NCs are known to exhibit improved
colloidal stability [26]. Besides, they are muco- [27] and bioadhesive towards negatively charged
biological membranes [28]. These NCs have been used as a drug delivery platform for insulin [29],
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flavonoids that interfere with bacterial quorum sensing [30], poorly water-soluble capsaicin [31,32],
or vaccines [33]. Despite the fact that these NCs have consistently shown efficacy as drug delivery
carriers, the precise mechanistic aspects that govern the interactions with the body and cellular fate
upon being administered, are not fully understood.
This study aims to examine the labelling of CS NCs by FRET and perform a physicochemical
characterization of these systems in comparison with unlabelled ones. FRET is studied using donor
quenching and sensitized emission of the acceptor dye and compared between dyes in solution and
dyes associated with NCs. FRET was measured in NCs that contain both donor and acceptor dyes and
mixtures of NCs that contain either donor or acceptor to determine if intra-NC and inter-NC FRET
occurred. As a model of NC disintegration, ethanol was used to dissolve NCs, and FRET, absorbance
at 650 nm, and count rate were measured. Finally, we studied the in vitro degradation of NCs using
pancreatin and found that protein corona formation affects their degradation rates, as probed by
dynamic light scattering (DLS) measurements.
2. Materials and Methods
2.1. Materials
Chitosan HMC 70/5 (Batch No. 212-140311-02) with a degree of acetylation of 32%
(as determined by 1H NMR) and MW = 5.01 × 104 g/mol and Ip = 2.18 (as determined by
SEC-HPLC with MALLS-DRI-IV multidetection in 0.3 M acetic acid/0.2 M sodium acetate
buffer) was obtained from Heppe Medical Chitosan GmbH (Halle, Germany). Miglyol® 812
(a neutral oil formed by esters of caprylic and capric fatty acids and glycerol) was kindly
provided by Peter Cremer Oleo (Hamburg, Germany). The surfactant lecithin (Epikuron®
145v, a phosphatidylcholine enriched fraction of soybean lecithin) was kindly supplied
by Cargill Germany (Krefeld, Germany). Lipophilic dyes 3,3′-Dioctadecyloxacarbocyanine
perchlorate (DiO), 1,1-Dioctadecyl-3,3,3,3-tetramethy-lindocarbo-cyanine iodide (DiI),
1,1′-dioctadecyl-3,3,3′,3′-tetramethy-lindodicarbocyanine, 4-chlorobenzenesulfonate salt (DiD)
and 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide (DiR) were purchased from Santa
Cruz Biotechnology (Heidelberg, Germany). Pancreatin from porcine pancreas was purchased from
Merck (Darmstadt, Germany), dissolved in PBS (pH = 7.4, Merck, Darmstadt, Germany) and clarified
by centrifugation at 5000× g for 10 min. Afterwards, the supernatant was filtered through 0.45 µm
syringe filters to avoid interference of insoluble protein with dynamic light scattering measurements.
Bovine serum albumin was purchased from Merck (Darmstadt, Germany). MilliQ water with a
resistivity of 18.2 MΩ at 25 ◦C and passed through a filter with a pore size of 0.22 µm was used
throughout. All other reagents used were of analytical grade, if not specified otherwise.
2.2. Nanocapsule Preparation
NCs and NEs were prepared by the solvent displacement technique first described by
Calvo et al. [34], with some modifications. Briefly, an organic phase was formed by dissolving 40 mg of
lecithin in 1 mL of ethanol, followed by the addition of 125 µL of Miglyol® 812 and lipophilic dyes
DiO, DiI, DiD and/or DiR and adding ethanol up to 10 mL (in the original protocol of Calvo et al. [34],
acetone is used in the organic phase instead of ethanol). This organic phase was immediately poured
over 20 mL of the aqueous phase composed of a chitosan solution (0.5 mg/mL dissolved in water with
5% stoichiometric with 1 M HCl excess). NCs were formed spontaneously due to the organic solvents
diffusion and Marangoni effects of the organic phase [35]. Finally, the ethanol and some of the water
were evaporated at 40 ◦C under vacuum on a R-210 Rotavapor (Büchi Labortechnik GmbH, Essen,
Germany) and the volume of the formulations was reduced to 10 mL. The association efficiency of
dyes was determined using Vivaspin 2 ultrafiltration cartridge filters of polyethersulfone (PES) with a
molecular weight cut-off of 30,000 kDa membrane purchased from Sartorius (Göttingen, Germany).
To this end, NCs were diluted 1:100 in water and centrifuged through the ultrafiltration membranes at
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4000× g for 10 min. Afterwards, absorbance scans were recorded of both the original dispersion and
the filtrate (see details below).
2.3. Size, Count Rate and Zeta Potential Measurements
Nanocapsules were characterized on the basis of average size distribution, size polydispersity,
count rate, and zeta potential. Particle size, polydispersion index, and count rate were determined by
dynamic light scattering with non-invasive back scattering (DLS-NIBS) at a measurement angle of 173◦.
The autocorrelation functions were fitted with the default non-negative least squares (NNLS) fit to
calculate the intensity size distribution plots and thus evaluate the Z-average diameter. For count rate,
derived count rate values were used, which are independent from the used attenuator setting. The zeta
potential was measured by mixed laser Doppler velocimetry and phase analysis light scattering
(M3-PALS). A Malvern Zetasizer NanoZS (Malvern, UK) fitted with a red laser (λ = 632.8 nm) was used
for both methods. The Zeta Sizer Software (v 7.12, Malvern, UK) was used to acquire and evaluate the
data. Samples were diluted 1:100 before the measurements, and these were carried out in triplicate.
2.4. Absorbance and Fluorescence Measurements
Absorbance measurements were recorded using a JASCO V-630 spectrophotometer
(Groß-Umstadt, Germany) with 1 mL Hellma quartz cells (Mühlheim, Germany) and a light path
length of 10 mm. We used absorbance measurements at 650 nm, where absorbance of the dyes (DiO-DiI)
was negligible to determine the presence of NCs by turbidity of the dispersion.
Fluorescence measurements were performed using a Tecan Safire Microplate reader (Crailsheim,
Germany). Due to potentially variable distances and orientations of donor and acceptor molecules
in the core of the NCs, the standard equations to calculate FRET efficiencies do not apply. Therefore,
relative values for FRET were calculated as the FRET index by measuring the donor emission in the
presence and absence of the donor using the following formula [36]:
FI = 1− IDAID , (1)
with FI = FRET index, IDA = donor emission in presence of the acceptor and ID = donor emission in
absence of the acceptor.
2.5. Enzymatic Degradation
Enzymatic degradation was studied using a constant concentration of NCs and varying the
concentration of soluble fraction of pancreatin. Measurements were performed in PBS (pH = 7.4) by
dissolving the indicated amount of enzyme in PBS and diluting the NCs 1:100 in the PBS-enzyme
solution. For measurements studying the influence of protein corona on the enzymatic degradation of
NCs by pancreatin, the NCs were diluted 1:100 in a PBS solution containing 4% BSA, except for the
BSA−-control for 20 min while derived count rate was recorded. After 20 min (t = 0 min), pancreatin
was added to the appropriate samples and the measurements continued for an additional 50 min.
All derived count rate measurements were normalized to the timepoint t = −20 min to account for
differences in derived count rate due to the presence or absence of BSA.
3. Results and Discussion
3.1. Physicochemical Characterization of NCs
Figure 1 shows the physical characteristics, namely the hydrodynamic diameter distribution
and average zeta potential, of unloaded CS-coated NCs, NCs loaded with DiO, DiI, a 1:1 mixture
of both DiO-loaded NCs and DiI-loaded NCs, and individual NCs labelled with both dyes. Of
note, there were almost no differences in the size distribution curves (Figure 1a), when labelled and
unlabelled NCs was compared. The size of all different formulations oscillated around a Z-average
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hydrodynamic diameter of ~130 nm and zeta potential around ~+45 mV. However, mixing DiO-
with DiI-loaded NCs resulted in a slightly elevated zeta potential (+50 mV), in comparison with
their individual components; this increase could be related to the greater concentration of NCs in
that sample. Regarding the association efficiency of the fluorescent dyes, we analysed the amount
of unassociated fraction of each by centrifuging a DiO-DiI-NC dispersion over the PES membranes
that prevented the NCs from passing through the membrane (see Figure A1). By dividing the peak
absorbance for DiO and DiI after filtration by peak absorbance before filtration, we obtained association
efficiencies of 98.28% and 98.37%, respectively. We found similar association efficiencies for closely
related dyes (listed in Table A1), which allowed flexibility in labelling the near-infrared range.
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Figure 1. Physicochemical characterization of loaded and unloaded nanocapsules (NCs) by DLS-NIBS.
(a) Scattering intensity over size; and (b) Zeta potential measured by diluting NC stocks 1:100 in
water at 25 ◦C. Error bars in (b) represent standard deviation from 10 sub-runs used in the zeta
potential measurements.
The similarity between the Z-average size and zeta potential values of the developed
dye-loaded NCs and those previously reported for NCs formulations using chitosans of varying
MW (9572–279,200 g mol−1) and DA (1.6–57%) [26,31,32,34] suggests that the overall physical
characteristics of these NCs seem to be hardly affected by the amount and nature of the compound
enca sulated in he oil core [31], s confirm in this s udy f r dye molecules that are more lipophilic
than the previously studied ones (cf., capsaicin; pr dicted partition coefficient (log P) D O: 18.13 [37];
log P caps icin: 3.81 [38]). The overall higher log P of the two examined dye molecules probably
increased their capacity to associate within the oily core of the NCs to close to 100%, a value greater
than the ~60–96% association efficiency previously determined for capsaicin-loaded NCs [31,32].
In previous studies, similar physicochemical characteristics examined by DLS were found for these
nanocarriers, lacking fluorescent dyes, also studied the morphology and ultrastructure by transmission
electron microscopy and synchrotron small-angle X-ray scattering (SAXS). The NCs were found to have
spherical morphology with a core shell structure, and while the main driver of CS deposition on the
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surface was electrostatic interactions of CS and lecithin, SAXS revealed that hydrophobic interactions
between hydrophobic moieties of CS and the lipid nucleus were also at play [31,32].
Strong affinity of the fluorescent dye for the NCs is a desired property, since this abrogates the
need to isolate labelled NCs from free dye molecules. Although in this case, the extremely low water
solubility of the dye molecules poses a challenge when trying to determine its release in vitro using
completely aqueous environments. However, in experiments including cells in culture or in vitro
(i.e., in the presence of cell membranes), the lipophilic dye molecules are readily able to associate with
cell membranes upon release from the nanoparticles [22,25].
Figure 2 shows a comparison of absorbance spectra and fluorescence emission spectra of equimolar
mixtures DiO/DiI at varying total concentrations (between 4.9 µM and 158 µM) in ethanol on their own,
and at similar concentrations and measured in PBS upon loading them in nanocapsules. The absorbance
measurements have shown overall higher absorbance for the encapsulated dyes due to added turbidity
by the NCs, although the dye peaks can easily be distinguished up to a dye concentration of 39.5 µM.
Of note, when diluted in ethanol, upon exciting DiO (λex = 484 nm), its fluorescence emission band
(λem = 505 nm) clearly increased with concentration. In addition, a slight bleedthrough to the acceptor
(DiI) was also noticed at λ = 565 nm (Figure 2b). By contrast, upon encapsulation, the DiO emission was
almost completely quenched even at the highest concentration, while the acceptor emission strongly
increased when compared with measurements in ethanol. Direct excitation of DiI (λex = 549 nm) in
both environments only showed slightly higher emission for the encapsulated dyes (Figure 2c).
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Figure 2. Spectroscopic properties of equimolar mixtures of DiO/DiI diluted in ethanol and equivalent
concentrations of DiO/DiI in nanocapsules diluted in PBS (as shown in label). (a) Absorbance
spectra. (b) Fluorescence emission spectra of DiO (donor), upon excitation (indicated by dotted
line, λex = 484 nm). (c) Fluorescence emission spectra of DiI upon excitation (indicated by dotted line,
λex = 549 nm).
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The extinction measured by spectrophotometry of a NC dispersion is the combined effect of
absorbance and scattering. In our case, this is due to dye molecules with strong absorbance in the
visible spectrum and to the scattering caused by dispersed capsules. Given the sizes reported for the
NCs above, scattering can be attributed to a mixture of Mie scattering (RH ~λ) and Rayleigh scattering
(RH ~ 110λ) [39], assuming a previously reported spherical shape of the chitosan coated NCs [31].
From 450 to 590 nm, RH is greater than 110λ and Mie scattering predominates, meaning that all
wavelengths of the visible spectrum are scattered equally. This results in a higher overall absorbance of
the dilutions of the dyes in NCs compared to the dyes dissolved in ethanol. A strong fluorescence
quenching is observed when exciting the donor in the presence of the acceptor in the case of NCs as
compared to the dyes dissolved in ethanol, while the acceptor emission is almost unaffected when
excited directly; this is an unequivocal hallmark of FRET at play. Due to the larger distance between
dye molecules and overall greater mobility, no energy transfer can take place when dyes are diluted
in ethanol, whereas the increased spatial proximity inside NCs (i.e., oil volume was 80-fold smaller
compared to aqueous medium at the highest dye concentration) provided an environment for efficient
energy transfer between dye molecules. FRET labelling of nanoscale systems using lipophilic tracer
dyes, with a similar approach and findings as in this study, has been adopted to examine synthetic
polymeric particles [25] and polymer coated and uncoated synthetic nanoemulsions [23,24].
Figure 3 shows that upon mixing NCs containing either the donor or acceptor dyes, only a slight
negative shift of the donor emission from that of the controls is obtained by measuring donor and
acceptor NCs individually. By contrast, NCs containing both the donor and acceptor dyes display the
previously shown behaviour of donor quenching and enhanced acceptor emission, deviating strongly
from the spectra obtained for donor and acceptor NCs.
Nanomaterials 2018, 8, x FOR PEER REVIEW  7 of 16 
 
visible spectrum and to the scattering caused by dispersed capsules. Given the sizes reported for the 
NCs above, scattering can be attributed to a mixtur  of Mie scattering (RH ~ λ) and Rayl igh scattering 
(RH ~  ଵଵ଴λ) [39], assuming a previously reporte  spherical shape of the chitos n coated NCs [31]. 
From 450 to 590 nm, RH is greater than ଵଵ଴λ and Mie scattering predominates, meaning that all 
wavelengths of the visible spectrum are scattered equally. This results in a higher overall absorbance 
of the dilutions f the dyes in NCs compared to the dyes dissolved in ethanol. A stro g fluorescence 
quenching is ob erved when exciting the donor in the presence of the acceptor in the case of NCs as 
compar  to the dyes dissolved in ethanol, while the acceptor emission is almost unaffected when 
excited directly; this is an unequivocal hallmark of FRET at play. Due to the larger distance between 
dye molecules and overall greater mobility, no energy transfer can take place when dyes are diluted 
in ethanol, whereas the increased spatial proximity inside NCs (i.e., oil volume was 80-fold smaller 
compared to aqueous medium at the highest dye concentration) provided an environment for 
efficient energy transfer between dye molecules. FRET labelling of nanoscale systems using lipophilic 
tracer dyes, with a similar approach and findings as in this study, has been adopted to examine 
synthetic polymeric particles [25] and polymer coated and uncoated synthetic nanoemulsions [23,24]. 
Figure 3 shows that upo  mixing NCs containi g either the donor r acceptor dyes, only a slight 
negative shift of the donor emission from that of the controls is obtained by measuri g donor and 
acceptor NCs individually. By contrast, NCs containing both the donor and acc ptor dyes display the 
previously shown behaviour of donor quenching and enhanced acceptor emission, deviating 
strongly from the spectra obtained for donor and acceptor NCs. 
 
Figure 3. (a) Scheme of a mix of DiO- and DiI-loaded nanocapsules (NCs) and DiO/DiI-loaded NCs, 
and (b) Differential fluorescence spectra corrected by subtracting spectra of DiO NCs and DiI NCs 
from spectra of a physical blend of DiO- and DiI-loaded (0.158 µM) NCs and equimolar DiO/DiI-
loaded NCs (0.158 µM) at the peak DiO excitation wavelength (λex = 484 nm). 
The slight negative emission observed for mixed donor- and acceptor-loaded NCs can be 
accounted for by the doubling in concentration of NCs needed to obtain the same concentration of 
both dyes in the dispersion. The NCs themselves scatter some of the incident and emitted light, while 
functioning as an inner filter, thus resulting in slightly lower fluorescence intensities [40]. The absence 
of FRET in this case indicates that the distance between capsules and hence, the distance between dye 
molecules, is too large (>10 nm) to establish inter-capsular FRET. When both dyes are loaded into the 
same NC, intra-capsular FRET is at play. 
3.2. Dissolution and Enzymatic Degradation of NCs 
The idea of FRET-labelling of drug delivery nanoparticles stems in the difficulty of studying 
their fate and the release of the payload when administered to cells in culture or in in vivo models. 
In this paper, we present an in vitro model to examine the degradation of NCs. For this purpose, we 
Figure 3. (a) Scheme of a mix of DiO- and DiI-loaded nanocapsules (NCs) and DiO/DiI-loaded NCs,
and (b) Differential fluorescence spectra corrected by subtracting spectra of DiO NCs and DiI NCs from
spectra of a physical blend of DiO- and DiI-loaded (0.158 µM) NCs and equimolar DiO/DiI-loaded
NCs (0.158 µM) at the peak DiO excitation wavelength (λex = 484 nm).
The slight negative emission observed for mixed donor- and acceptor-loaded NCs can be
accounted for by the doubling in concentration of NCs needed to obtain the same concentration of
both dyes in the dispersion. The NCs themselves scatter some of the incident and emitted light, while
functioning as an inner filter, thus resulting in slightly lower fluorescence intensities [40]. The absence of
FRET in this case indicates that the distance between capsules and hence, the distance between dye
molecules, is too large (>10 nm) to establish inter-capsular FRET. When both dyes are loaded into the
same NC, intra-capsular FRET is at play.
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3.2. Dissolution and Enzymatic Degradation of NCs
The idea of FRET-labelling of drug delivery nanoparticles stems in the difficulty of studying
their fate and the release of the payload when administered to cells in culture or in in vivo models.
In this paper, we present an in vitro model to examine the degradation of NCs. For this purpose,
we first dissolved dye-loaded NCs at different water/ethanol mixtures and measured their FRET
index, absorbance at 650 nm, and derived count rate and particle size (Figure 4). The FRET index
(FI), calculated by measuring the intensity of the donor in the presence of the acceptor divided by the
intensity of the donor in absence of the acceptor (Equation (1)), showed a decrease of FI for the NCs that
contain both dyes (donor and acceptor) in the same NCs, starting at ethanol concentrations higher than
0.4 (v/v) and decreasing further up to pure ethanol (Figure 4a). By contrast, physical blends of NCs
that contained either donor or acceptor and showed no FRET in an aqueous environment (Figure 3b)
exhibited FRET upon addition of ethanol at 0.4 and 0.6 (v/v), as shown in Figure 4a. In addition,
the derived count rate (DCR) showed a sharp decrease with increasing ethanol/water ratios. Indeed,
the DCR changed from 100,000 to 200 kcps upon addition of ethanol at ratios of 0.45 and 0.6 (v/v).
This change was also accompanied by an increase in the Z-average sizes and PDI, albeit under a
less-pronounced trend than the decrease in DCR. Absorbance (λ = 650 nm) also showed a step decrease
at ethanol/water ratios (Figure 4c) of 0.4 to 0.6 (v/v). Additionally, for NCs containing only DiO,
a slight shift of the DiO emission peak from 507 to 504 nm was observed from water to ethanol
(Figure A2, Table A2).
Nanomaterials 2018, 8, x FOR PEER REVIEW  8 of 16 
 
first dissolved dye-loaded NCs at different water/ethanol mixtures and measured their FRET index, 
absorbance at 650 nm, and derived count rate and particle size (Figure 4). The FRET index (FI), 
calculated by measuring the intensity of the donor in the presence of the acceptor divided by the 
intensity of the donor in absence of the acceptor (Equation (1)), showed a decrease of FI for the NCs 
that contain both dyes (donor and acceptor) in the same NCs, starting at ethanol concentrations 
higher than 0.4 (v/v) and decreasing further up to pure ethanol (Figure 4a). By contrast, physical 
blends of NCs that contained either donor or acceptor and showed no FRET in an aqueous 
environment (Figure 3b) exhibited FRET upon addition of ethanol at 0.4 and 0.6 (v/v), as shown in 
Figure 4a. In addition, the derived count rate (DCR) showed a sharp decrease with increasing 
ethanol/water ratios. Indeed, the DCR changed from 100,000 to 200 kcps upon addition of ethanol at 
ratios of 0.45 and 0.6 (v/v). This change was also accompanied by an increase in the Z-average sizes 
and PDI, albeit under a less-pronounced trend than the decrease in DCR. Absorbance (λ = 650 nm) 
also showed a step decrease at ethanol/water ratios (Figure 4c) of 0.4 to 0.6 (v/v). Additionally, for 
NCs containing only DiO, a slight shift of the DiO emission peak from 507 to 504 nm was observed 
from water to ethanol (Figure A2, Table A2). 
 
Figure 4. Effect of dissolution of fluorescently labelled nanocapsules (NCs) with increasing 
concentrations of ethanol, as characterized, by: (a) FRET index of a physical blend of DiO- and DiI-
loaded (0.158 µM) NCs and equimolar DiO/DiI-loaded NCs (0.158 µM); (b) Derived count rate and 
Z-average size of equimolar DiO/DiI-loaded NCs (0.158 µM) by DLS-NIBS; and (c) Absorbance (λ = 
650 nm) of equimolar DiO/DiI-loaded NCs. FRET index was calculated by measuring DiO (donor) 
emission in the presence and absence of DiI (acceptor) using Equation (1). Full spectra used to 
calculate FRET index are shown in Figure A1. Error bars represent standard deviation of triplicate 
measurements in all cases, except for size, where error bars represent mean PDI width in nm of 
triplicate measurements. 
The diminishing FI at increasing ethanol ratios observed for DiO/DiI-loaded NCs, alongside the 
change in the DiO peak emission wavelength and strongly decreasing count rate, is diagnostic 
evidence that the NCs are dissolved as the ethanol/water ratio attains a critical value between 0.4 to 
0.6 (v/v). It was interesting to see that mixtures of DiO NCs and DiI NCs, which did not exhibit FRET 
in aqueous environments, started to exhibit a FRET at ethanol/water ratios >0.2 (v/v), with maximal 
Figure 4. Effect of dissolution of fluorescently labelled nanocapsules (NCs) with increasing
concentrations of ethanol, as characterized, by: (a) FRET index of a physical blend of DiO- and
DiI-loaded (0.158 µM) NCs and equimolar DiO/DiI-loaded NCs (0.158 µM); (b) Derived count rate
and Z-average size of equimolar DiO/DiI-loaded NCs (0.158 µM) by DLS-NIBS; and (c) Absorbance
(λ = 650 nm) of equimolar DiO/DiI-loaded NCs. FRET index was calculated by measuring DiO
(donor) emission in the presence and absence of DiI (acceptor) using Equation (1). Full spectra used to
calculate FRET index are shown in Figure A1. Error bars represent standard deviation of triplicate
measurements in all cases, except for size, where error bars represent mean PDI width in nm of
triplicate measurements.
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The diminishing FI at increasing ethanol ratios observed for DiO/DiI-loaded NCs, alongside the
change in the DiO peak emission wavelength and strongly decreasing count rate, is diagnostic evidence
that the NCs are dissolved as the ethanol/water ratio attains a critical value between 0.4 to 0.6 (v/v).
It was interesting to see that mixtures of DiO NCs and DiI NCs, which did not exhibit FRET in aqueous
environments, started to exhibit a FRET at ethanol/water ratios >0.2 (v/v), with maximal FI values
only slightly below those of DiO/DiI-loaded NCs. We suggest that this is the consequence of an
increased solubility of the strongly hydrophobic dyes, originally trapped in the oily core of the NCs,
in the ethanol/water mixed solvent and their resulting ability to interchange donor and acceptor dye
molecules between NCs. Another possibility would be that the change in the overall polarity of the
solvent brought by the addition of ethanol leads NCs to flocculate and coalesce, thus bringing donor
and acceptor dyes into close contact. This proposal would be supported by the larger sizes attained
with increasing ethanol ratios. The accompanying observed drastic drop in DCR at ethanol/water
ratio of ~0.45 (v/v) could be interpreted as the result of the decrease in the overall number of coalescing
particles. However, given that the size distribution measured by the intensity of light scattering
by DLS-NIBS is sensitive to both the size and the overall number of particles, we can only offer a
speculative interpretation to these results. Other complementary techniques, such as nanotracking
analysis (NTA), which are amenable for characterizing the particle size distribution by number, may be
informative in this regard in future studies.
The putative interexchange of dye molecules between NCs at intermediate ethanol/water
compositions could have interesting implications on the behaviour of lipophilic molecules during
the formation of the NCs using the solvent displacement technique. NCs are originally formed at
a 0.33 ethanol/water ratio and from our results it seems feasible that loaded molecules, especially
more hydrophilic molecules than the dyes used for this study, could still be exchanged between NCs.
Release experiments in aqueous media often poorly predict the release of lipophilic drugs due to the
lack of acceptors like cell membranes and lipid particles that are present in vivo. Previous studies
have shown the use of single dye transfer between different lipophilic carriers like liposomes and
lipid nanoparticles [41,42]. The use of dyes capable of FRET with different fat solubility or loading
in separate NCs to study transfer kinetics could remove the need for separation by centrifugation or
flow cytometry.
Fluorescence emission intensity and peak shifts of lipophilic dyes are frequently used to determine
critical micellular concentrations (CMC) of surfactants [43,44]. Even when our experimental set-up
was not designed to measure surfactant CMCs (e.g., of lecithin), the observed DiO emission blue shift
could be taken as an indicator for a polarity change in its environment (i.e., a change from the strongly
hydrophobic environment of the oily core of the NCs to the moderately hydrophobic environment of an
ethanol-oil-lecithin solution). We did not observe a strong difference in fluorescence intensity between
dye molecules associated with the NC oily core and NCs dissolved in ethanol, usually observed
in DiO and related dyes [44]. Differences in fluorescence intensity are not expected to be as strong
between the oily core and ethanol as previously reported differences between aqueous solutions and
organic solvents because of a lower difference in polarity. The absence of emission intensity differences
could also be due to an inner filter effect of the NCs quenching the incident and emission light.
Figure 5 shows the results of the enzymatic degradation of NCs using pancreatin. Notice in
Figure 5a,b that the normalized DCR size measurements were found constant when no pancreatin
was present, whereas at higher enzyme concentration the degradation velocity increased in a linear
fashion, as indicated by a linearly increasing rate constant between 0.001 and 0.01 mg/mL added
pancreatin concentration. NC size decreased in samples containing pancreatin; greater the reduction
the higher the pancreatin concentration is. However, there was a large overlap between concentrations.
In a separate experiment, we determined the influence of a protein corona (BSA) on the degradability of
the NCs (Figure 5d). Addition of 4% BSA yielded a slow decrease of DCR over 70 min, whereas in
PBS without BSA, count rate was stable until pancreatin was added. After addition of pancreatin
in samples without BSA, count rate was rapidly reduced to below 10% after 10 min. By contrast,
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the decrease was lower in samples containing BSA, reaching about 40% after 10 min, even though it
had already decreased to about 80% before the addition of pancreatin due to BSA alone.
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CS NCs as diluted 1:100 in PBS and PBS with 4% bovine serum albumin as measured by derived
count rate relative to initial values. Pancreatin was added at timepoint zero (dotted line) to a final
concentration of 0.1 mg/mL for non-control samples. All measurements were performed at 37 ◦C
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Enzy atic digestion of nanoparticles is an i portant aspect to consider before their pre-clinical
in vivo ad inistration studies or clinical applications can be translated. This knowledge is necessary to
ensure biocompatibility and full clearance of degraded components fro the body’s tissues and
prevent accu ulation to toxic levels. Depending on the route of ad inistration, nanoparticles will be
in contact with different enzy es, pancreatin being an exa ple of a ixture of enzy es present in
the gastrointestinal tract relevant to oral ad inistration. Pancreatin is a ixture of α-a ylase, lipase,
phospholipase and protease, which should be able to degrade all co ponents of the NCs, except CS.
In our experiments, however, we have shown that the CS-coated nanocapsules are readily degradable
by pancreatin in PBS, as evidenced by the rapid reduction in DCR upon contact with the enzy es.
Interestingly, the Z-average size did not decrease to zero even after 10 h, even when the DCR values
reached their lowest level at a pancreatin concentration of 0.01 mg/mL. This could potentially be
due to either a processive mode of enzymatic degradation, where there is a population of NCs that
are destabilized and being degraded, while others remain intact, or a residual population of NCs that
persists undegraded, which tend to be overestimated by the DLS measurements when compared to
the decreasing size of NCs that are being degraded [45,46]. Unfortunately, unlike the dissolution of
the NCs using ethanol, we were not able to probe the in vitro enzymatic degradation using the FRET
approach presented in this paper, due to an overall decrease in fluorescence of both donor and acceptor
upon enzymatic degradation of the NCs, presented in Figure A3. While a decrease of donor emission
and increase in acceptor emission, both diagnostic hallmarks of FRET, were observed in the mixture of
DiO NCs and DiI NCs that contained enzymes, over the control, other samples only showed an overall
decrease in fluorescence. We attribute this to a probable photobleaching effect. In the mixture of NCs
containing only one dye, NCs were probably destabilized and dyes were able to mix, similarly to
the above discussed effects at intermediate ethanol concentrations. A lack of acceptors for lipophilic
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molecules in which the overall separation between dye molecules can increase upon release from
the NCs is a limitation for in vitro experiments using FRET. Attempts to increase the solubility of the
fluorescent dyes using surfactants failed due to inactivation of pancreatic enzymes. This could be
addressed in future in vitro or in vivo experiments, given that cell membranes present could perform
as acceptors for lipophilic dyes, as has been shown in previous studies [24].
The formation of a protein corona (PC) around nanoparticles is an expected phenomenon
when they enter in contact with the proteins occurring in biological fluids. The influence of PC
on pharmacokinetics, biodistribution, and biocompatibility has been of major interest recently [47–51].
Even though the combination of intestinal pancreatin and nanoparticles coated with a PC of BSA is
an unrealistic in vivo scenario, simple in vitro models to elucidate the effects of protein adsorption
on nanoparticles are needed to establish structure-function relationships prior to in vivo testing and
clinical trials [48,52]. In our study, we found that adsorption of BSA slightly decreased the DCR of
chitosan-coated NCs over time, probably due to an aggregation and sedimentation effect, given that NC
size did not increase concomitantly. BSA was effective in forming a PC around NCs, which decreased
accessibility of the NC to pancreatic enzymes, as detected by the lower degradation rates. We propose
that DCR measurements recorded by DLS-NIBS are a readily accessible experimental parameter
for quickly assessing either dissolution by solvents or enzymatic degradation of nanoparticles.
Measurement of DCR allows a first screening of interactions of nanoparticles with model biological
relevant environments, such as presence of pancreatic enzymes or BSA.
4. Conclusions
Altogether, our results have demonstrated that the labelling of CS-coated NCs using lipophilic
tracer dyes did not affect their size distribution and zeta potential. When FRET donor (e.g., DiO) and
acceptor (e.g., DiI) dye pair is co-loaded at equimolar ratios in NCs, the fluorescence emission of the
donor dye is strongly quenched, whereas that of the acceptor dyes is enhanced when compared to
the corresponding fluorescence of the dyes dissolved in ethanol. By contrast, no FRET was observed
when dyes were loaded individually into NCs and mixed, thus indicating that FRET was only possible
inside the oily core of the same NC, but not between different NCs. Dissolution of the NCs by partial
addition of ethanol showed a decreasing FRET index for NCs loaded with both DiO and DiI. This was
accompanied by a decrease in count rate and decrease in turbidity. On the other hand, physical
blends of NCs loaded with either DiO or DiI under an identical treatment, first increased in FRET
index and then decreased in a similar manner as DiO-DiI loaded NCs, which we interpret either as
an exchange of lipophilic dye molecules at intermediate ethanol concentrations, before the complete
dissolution of the NCs at high ethanol concentrations, or as the consequence of flocculation and
coalescence of the nanoparticles. Lastly, we showed that the NCs were degraded by pancreatin in a
dose-dependent manner and that a protein corona made from BSA decreased the rate of degradation.
Ultimately, only further research, either in vitro or in vivo, will clarify the significance and allow to
fully realize the application of the results presented here.
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Appendix A
Table A1. Excitation and emission maxima and predicted LogP for dyes encapsulated in NCs for
this study.
Tracer Dye Excitation Maximum (nm) 1 Emission Maximum (nm) 1 Log P 2
DiO 484 501 15.1
DiI 549 565 18.1
DiD 644 665 18.7
DiR 750 780 19.2
1 Data according to manufacturer manual. 2 Software prediction [37].
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